Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation NY Valves 2025

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Presenter: Fabio Sandoli de Brito

June 26, 2025

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2025

GDMT in FMR: What Every Interventionalist Needs to Know

Presenter: Sean P. Pinney

June 25, 2025

Presentation NY Valves 2025

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Advertisement

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

GDMT in FMR: What Every Interventionalist Needs to Know

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

CON: TMVR Has too Many Problems – Just Do M-TEER

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content